Andrew Sulaiman
- Biomaterials top 1%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 2
- Oncology top 10%
- Cancer Cells and Metastasis 9
- Cancer-related Molecular Pathways 3
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 2
- Wnt/β-catenin signaling in development and cancer 2
-
- Immunotherapy and Immune Responses 2
-
- Hippo pathway signaling and YAP/TAZ 4
-
- Cancer Research and Treatments 2
Andrew Sulaiman
16 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Biomaterials 723
- Biomedical Engineering 873
- Oncology 363
- Molecular Biology 717
- Immunology 205
Countries citing papers authored by Andrew Sulaiman
This map shows the geographic impact of Andrew Sulaiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Sulaiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Sulaiman more than expected).
Fields of papers citing papers by Andrew Sulaiman
This network shows the impact of papers produced by Andrew Sulaiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Sulaiman. The network helps show where Andrew Sulaiman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Sulaiman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 35 | |
| 6 | 2021 | 17 | |
| 7 | The entry of nanoparticles into solid tumoursbreakdown → | 2020 | 1293 |
| 8 | 2020 | 4 | |
| 9 | 2020 | 12 | |
| 10 | 2019 | 21 | |
| 11 | 2019 | 31 | |
| 12 | 2018 | 37 | |
| 13 | 2018 | 60 | |
| 14 | 2017 | 77 | |
| 15 | 2017 | 26 | |
| 16 | 2017 | 40 | |
| 17 | 2016 | 28 | |
| 18 | 1989 | 9 |
About Andrew Sulaiman
Andrew Sulaiman is a scholar working on Oncology, Cell Biology and Biotechnology, having authored 18 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Hippo pathway signaling and YAP/TAZ (4 papers), Cancer-related Molecular Pathways (3 papers), Cancer Research and Treatments (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Immunotherapy and Immune Responses (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Biomaterials (723 citations), Biomedical Engineering (873 citations) and Oncology (363 citations). Andrew Sulaiman has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Suresh Gadde, Presley MacMillan, Stefan Wilhelm, Anton Zilman, Zachary P. Lin, Shrey Sindhwani, Jessica Ngai, Netra U. Rajesh, Mikala Egeblad and Abdullah M. Syed. Their work appears in journals such as Nature Materials, FEBS Letters and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.